Overview: Dengue Virus PCR TestIntroduction: The Dengue Virus PCR Test detects dengue virus DNA, confirming active infection causing fever or joint pain. Aligned with 2023 WHO guidelines, it uses PCR for high specificity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in virology for patients with suspected acute dengue infections.
Other Names: Dengue PCR Assay, Dengue DNA Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: Dengue PCR testing began in the 2000s with molecular diagnostics. Real-time PCR emerged in the 2010s, improving detection accuracy for active infections.
Purpose: Confirms active dengue infection, guides supportive care, and monitors viral DNA in patients with fever or joint pain.
Test Parameters: 1. Dengue Virus DNA
Pretest Condition: No fasting required. Collect whole blood, serum, plasma, or saliva at any time. Report symptoms like fever or joint pain, and list recent travel to dengue-endemic areas.
Specimen: 2-5 mL whole blood (EDTA), 2-5 mL serum (SST), 2-4 mL plasma (EDTA), or 1-2 mL saliva (sterile container). Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fever, joint pain, or travel to dengue-endemic areas. Include current medications, especially antipyretics.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for supportive care.
Procedural Considerations: Uses real-time PCR to detect dengue virus DNA. Results are available in 3-5 days, supporting clinical decisions.
Factors Affecting Result Accuracy: Low viral load or improper storage can cause false negatives. Contamination may cause false positives.
Clinical Significance: Positive DNA results confirm active dengue infection, prompting supportive care. Negative results may require NS1 or IgM testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation.
Additional Supporting Tests: Dengue NS1 antigen, IgM/IgG, or complete blood count to confirm infection or assess complications.
Test Limitations: False negatives may occur with low viral load. Results require clinical correlation.
References: WHO Dengue Guidelines, 2023; Clinical Infectious Diseases, Guzman MG, 2022.
